Confirmed speakers

• José Carballido, Novartis, Basel, CH (Keynote)
  Immune Tolerance: A backward glance into the future
• Martin R. Jakobsen, UNIKUM, Aarhus, DK
  Plasmacytoid dendritic cells for use in cellular therapies
• Antoon van Oosterhout, Imcyse, Liege, BE
  Bench-to-bedside: Imotope™-based antigen-specific immunotherapy for autoimmune diseases
• Peter J. Holst, InProTher, Copenhagen, DK
  Active Immunotherapies targeting cancer associated endogenous retroviruses
• Marina Romero-Ramos, Aarhus University, Aarhus, DK
  Monocyte changes during Parkinson’s Disease
• Bjarke Hviid-Vyff, Aarhus University Hospital, Aarhus, DK
  Intralymphatic Immunotherapy: An innovative treatment of grass pollen allergy
• Stefan Vieths, Paul-Ehrlich-Institute, Langen, DE
  Regulatory requirements for Allergen Immunotherapy Products in the European Union